| Biocontrol is working to develop safe, specific, effective and adaptable biological agents, targeted at markets where current chemical drugs are failing or ineffective. |
| Evaluation of multiple potential product areas has been undertaken using grant and seed funding, which has resulted in multiple potential product development streams. |
| This has allowed the company to conduct both preclinical work and clinical trials both rapidly and economically. |
| Biocontrol's lead product is based on 15 years of research on bacteriophage-based control of Pseudomonas aeruginosa infections. |
| The company has built on this to develop a world leading position in the application of bacteriophage technology to the control of human disease. |
| The company has now completed initial clinical trials of its lead product. This is a treatment based on the use of bacteriophages- naturally occurring agents that specifically target and destroy infecting bacteria. |
| Download the current company brochure here |